Fenwick has advised Scribe Therapeutics. Latham & Watkins has advised the underwriters. Scribe Therapeutics Inc., a clinical-stage biotechnology company specializing in in vivo CRISPR technologies, has...
Scribe Therapeutics Completes $155.51 Million Initial Public Offering and Private Placement
Revmatics Acquires DataFeedWatch from Cart.com
Latham & Watkins has advised Revmatics. Gunderson Dettmer has advised Cart.com. Revmatics, an AI-driven revenue platform specializing in transforming marketing data into measurable revenue, has acquired...
Serapha Bio and Boundless Bio Announce Merger and $230 Million Private Placement
Gibson Dunn has advised Serapha Bio, Inc. Latham & Watkins has advised Boundless Bio, Inc. Serapha Bio, Inc., a privately held biotechnology company, and Boundless Bio,...
Beren Therapeutics Secures $300 Million in Equity, Debt, and Royalty Financing
Wilson Sonsini Goodrich & Rosati has advised Beren Therapeutics P.B.C. Latham & Watkins has advised Hercules Capital, Inc. Beren Therapeutics P.B.C., a biotechnology company and parent...
Mineralys Therapeutics Announces Royalty Repurchase, $500 Million Debt Facility, and $150 Million Equity Offering
Latham & Watkins LLP has advised Mineralys Therapeutics. Cleary Gottlieb has represented the underwriters, including BofA Securities Inc., Goldman Sachs & Co. LLC, and Evercore Group...
Kennedy Wilson to be Acquired in US$1.65 Billion Consortium Take-Private Transaction
Latham & Watkins and Ropes & Gray have advised Kennedy Wilson. A&O Shearman has advised Fairfax Financial Holdings. Kennedy-Wilson Holdings, Inc. has entered into a definitive...
Mobia Medical Raises $150 Million in Initial Public Offering
Latham & Watkins LLP has advised Mobia Medical, Inc. Cleary Gottlieb has represented the underwriters. Mobia Medical, Inc., a commercial-stage medical device company, completed its initial...
USA Rare Earth Acquires Serra Verde Group in $2.8 Billion Deal
White & Case LLP and Allen Overy Shearman Sterling US LLP have advised Serra Verde Group. Latham & Watkins and Demarest have advised USA Rare Earth....
Forgent Power Solutions Launches Initial Public Offering on NYSE
Weil Gotshal & Manges has advised Forgent Power Solutions. Latham & Watkins LLP has represented the underwriters. Forgent Power Solutions, a prominent designer and manufacturer of...
Viridian Therapeutics Royalty Financing Agreement with DRI Healthcare for up to $300 Million
Ropes & Gray has advised Viridian Therapeutics. Weil and Ballard Spahr have advised DRI Healthcare. Latham & Watkins has advised the lender, Hercules Capital, on the...
HealthCare Royalty and Blue Owl Capital Acquire BridgeBio Pharma’s BEYONTTRA Royalty Interest for $300 Million
Gibson Dunn has advised HealthCare Royalty and Blue Owl Capital, and Latham & Watkins has advised BridgeBio Pharma. HealthCare Royalty and Blue Owl Capital have acquired...
Lineage Prices $500 Million Senior Notes Offering
Latham & Watkins LLP represented Lineage in the offering, while Paul Hastings LLP advised J.P. Morgan, BofA Securities and Wells Fargo Securities as representatives of the...